Figure 2A–E demonstrate that CEP55 protein expression was significantly elevated in breast cancer, glioblastoma multiforme, HNSC, ovarian cancer, and PAAD in comparison to the corresponding normal tissues. In addition to that, we explored the IHC figures of these tumors and their correlated normal tissues, and the findings matched with the results of differential protein expression as the staining for CEP55 was low or even undetected in normal tissue, while it was moderate to intense in the corresponding assessed tumors (Figure 2A–E). Here, CEP55 is linked to breast cancer.